| Literature DB >> 29924815 |
Nathalie Bonvallot1,2, Cécile Canlet2, Florence Blas-Y-Estrada2, Roselyne Gautier2, Marie Tremblay-Franco2, Sylvie Chevolleau2, Sylvaine Cordier1, Jean-Pierre Cravedi2.
Abstract
The use of pesticides exposes humans to numerous harmful molecules. Exposure in early-life may be responsible for adverse effects in later life. This study aimed to assess the metabolic modifications induced in pregnant rats and their offspring by a pesticide mixture representative of human exposure. Ten pregnant rats were exposed to a mixture of eight pesticides: acetochlor (246 μg/kg bw/d) + bromoxynil (12 μg/kg bw/d) + carbofuran (22.5 μg/kg bw/d) + chlormequat (35 μg/kg bw/d) + ethephon (22.5 μg/kg bw/d) + fenpropimorph (15.5 μg/kg bw/d) + glyphosate (12 μg/kg bw/d) + imidacloprid (12.5 μg/kg bw/d) representing the main environmental pesticide exposure in Brittany (France) in 2004. Another group of 10 pregnant rats served as controls. Females were fed ad libitum from early pregnancy, which is from gestational day (GD) 4 to GD 21. Urine samples were collected at GD 15. At the end of the exposure, mothers and pups were euthanized and blood, liver, and brain samples collected. 1H NMR-based metabolomics and GC-FID analyses were performed and PCA and PLS-DA used to discriminate between control and exposed groups. Metabolites for which the levels were significantly modified were then identified using the Kruskal-Wallis test, and p-values were adjusted for multiple testing correction using the False Discovery Rate. The metabolomics analysis revealed many differences between dams of the two groups, especially in the plasma, liver and brain. The modified metabolites are involved in TCA cycle, energy production and storage, lipid and carbohydrate metabolism, and amino-acid metabolism. These modifications suggest that the pesticide mixture may induce oxidative stress associated with mitochondrial dysfunction and the impairment of glucose and lipid metabolism. These observations may reflect liver dysfunction with increased relative liver weight and total lipid content. Similar findings were observed for glucose and energy metabolism in the liver of the offspring, and oxidative stress was also suggested in the brains of male offspring.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29924815 PMCID: PMC6010212 DOI: 10.1371/journal.pone.0198448
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Ingested doses of pesticides by dams (μg/kg bw/day), calculated from a total dose based on the sum of the acceptable daily intake (ADI) of each pesticide and the proportion to their level of environmental exposure in Brittany (France).
| Pesticide: | Theoretical oral dose | Dietary intake based on food consumption | ADI | Proportion of environmental pesticide exposure in Brittany (%) |
|---|---|---|---|---|
a acceptable daily intake from EFSA and Agritox, data from the Decision of the European Union, available at www.efsa.europa.eu and www.agritox.anses.fr, respectively;
b POD: point of departure (NOAEL: no observed adverse effect level, or LOAEL: lowest observed adverse effect level);
c the proportions of pesticide used in this study were defined from a registry of pesticide’s emissions achieved in 2003 in Brittany (France) by a regional association for air quality https://www.airbreizh.asso.fr/).
This registry was based on different practice’s surveys implemented on the water catchment scale, the physical chemical characteristics of the pesticides, and the spreading quantities at the square-kilometer scale.
Food consumption and body and organ weights for dams and offspring.
| Parameters | Control group | Exposed group |
|---|---|---|
| Food consumption (g) | 294.3 ± 18.3 | 317.2 ± 31.8 |
| Relative food consumption/body weight (%) | 1.43 ± 0.10 | 1.47 ± 0.13 |
| Body weight gain (g) | 97.5 ± 6.3 | 95.5 ± 13.3 |
| Body weight at GD21 (g) | 302.7 ± 12.6 | 312.2 ± 22.5 |
| Absolute liver weight (g) | 9.49 ± 0.82 | 8.98 ± 0.98 |
| Relative liver/ body weight (%) | ||
| Lipid mass per gram of liver (mg/g) | ||
| Brain weight (g) | ||
| Relative brain/ body weight (%) | 0.48 ± 0.06 | 0.50 ±0.03 |
| Number of offspring per litter | 11.39 ± 1.6 | 10.28 ± 1.6 |
| Number of males | 5.71 ± 1.03 | 5.47 ± 2.13 |
| Number of females | ||
| Liver weight | ||
| Males | ||
| Females | 0.56 ± 0.11 | 0.60 ± 0.08 |
| Lipid mass per gram of liver (mg/g) | ||
| Males | ||
| Females | 15.73 | 15.18 |
| Brain weight | ||
| Males | ||
| Females |
a Data shown as the mean ± SD.
b Comparison with the Kruskal Wallis test:
*p < 0.05;
**p < 0.01;
***p < 0.005.
c pool of three individuals per litter.
citrate
using the Kruskal-Wallis test shows a statistical significant increase in the exposed group compared to the control group (p = 0,001).Results of the partial least square modelling of metabolic profiles of dams (urine, plasma, aqueous liver and brain tissue extracts, and lipidic liver tissue extracts).
| Samples | Number of rats | Model used | Number of LV | R2 | Q2 | Intercepts | Number of VIP |
|---|---|---|---|---|---|---|---|
| 15 | OSC-pareto scaled + PLS-DA (mean centered) | 2 | 94.8% | 0.613 | R2 = (0.0, 0.665) Q2 = (0.0, -0.249) | 163 | |
| 20 | PLS-DA (pareto scaled) | 3 | 80.6% | 0.413 | R2 = (0.0, -0.472) Q2 = (0.0, -0.232) | 155 | |
| 14 | PLS-DA (pareto scaled) | 1 | 81.2% | 0.704 | R2 = (0.0, -0.277) Q2 = (0.0, -0.222) | 87 | |
| 20 | OSC-unit scaled + PLS-DA (unit scaled) | 1 | 93.3% | 0.835 | R2 = (0.0, 0.291) Q2 = (0.0, -0.166) | 7 | |
| 19 | PLS-DA (pareto scaled) | 2 | 86.5% | 0.552 | R2 = (0.0, 0.514) Q2 = (0.0, -0.231) | 165 |
a LV: latent variables.
b 200 permutations.
c VIP: variable importance in projection.
d exclusion of the citrate region (shift) and rat n°G2-18 (outlier in a preliminary PCA).
e exclusion of rats n°G2-17 and G0Mbis.
f exclusion of rat n°G2-Mter.
Fig 1Two-dimensional PLS-DA and PCA scores plot of pregnant rat samples integrated 1H NMR spectra.
1a: GD 15 urine samples (PLS-DA, A = 2, R2 = 94.8%, Q2 = 0.613); 1b: GD 21 plasma samples (PCA, A = 4, R2 = 72.5%); 1c: GD21 liver aqueous extract samples (PCA, A = 3, R2 = 61.6%); 1d: GD21 brain aqueous extract samples (PCA, A = 4, R2 = 72.8%). Each dot represents an observation (animal), projected onto first (horizontal axis) and second (vertical axis) PLS-DA or PCA variables. Control group is shown with black squares and the group exposed to eight pesticides widely used in Brittany (France) in 2004 (acetochlor, bromoxynil, carbofuran, chlormequat, ethephon, fenpropimorph, glyphosate, imidacloprid) is shown with red circles. The black ellipse determines the 95% confidence interval, which is drawn using Hotelling’s T2 statistic.
Plasma, liver and brain metabolite levels that were significantly different between dams from the exposed and control groups.
| Plasma | Liver aqueous | Brain aqueous | Biological role | |
|---|---|---|---|---|
| Hippurate | Gut microbial metabolism? | |||
| Citrulline | Urea cycle | |||
| Creatine | ↘ | ↗ | ↗ | Amino-acid synthesis, storage energy (phosphocreatine) |
| Phenylacetylglycine | Minor metabolites of fatty acids | |||
| Citrate | TCA cycle | |||
| Succinate | ↘ | TCA cycle | ||
| ATP | ↘ | Energy source | ||
| ADP/AMP | ↘ | Energy source | ||
| Glycerol | ↘ | Lipid component, converted to glucose for energy production | ||
| Glycogen | ↘ | Energy storage | ||
| Glucose | ↗ | Energy source | ||
| Lactate | ↘ | Energy metabolism | ||
| Alanine | ↘ | Energy source, glucose metabolism regulator | ||
| Glutamate | ↗ | ↘ | Neoglucogenesis, excitatory neurotransmitter | |
| Glutamine | ↘ | ↘ | ↘ | Non-essential amino-acid, role in TCA cycle |
| Valine | ↘ | Essential amino-acid involved in stress, energy and muscle metabolism, role in carbohydrate synthesis | ||
| Acetate (with lysine) | ↘ | ↗ | Lipid and carbohydrate metabolism | |
| Lipids | ↗ | ↘ | Lipid metabolism | |
| Aceto-acetate | ↗ | Lipid metabolism, cholesterol synthesis | ||
| 3-hydroxybutyrate | ↗ | Lipid metabolism. Energy source | ||
| Isoleucine | ↘ | ““ | ||
| Lysine (with acetate) | ↘ | ↗ | Essential amino-acid involved in stress, precursor of acetyl-coA | |
| Serine | ↘ | ↘ | Non-essential amino-acid derived from glycine | |
| Dimethylamine | ↗ | Gut microbial metabolism of choline, host co-metabolism | ||
| Dimethylgylcine | ↘ | Byproduct of homocysteine and glycine metabolism | ||
| Inosine | ↗ | Purine metabolism | ||
| Aspartate | ↘ | Non-essential amino-acid produced from glutamate, neurotransmitter. | ||
| N-acetylaspartate | ↗ | Neuronal osmolyte, lipid synthesis, derived from aspartate in brain | ||
| Oxidized gluthatione | ↗ | Anti-oxidant | ||
| Glycine | ↘ | Osmoprotector, defense mechanisms | ||
| Taurine | ↘ | ↗ | Membranes stabilizer in brain, antioxidant, osmolyte | |
| Glycero-phosphocholine | ↗ | ↘ | Membrane stabilizer, osmolyte | |
| Phosphocholine | ↘ | Membranes stabilizer, osmolyte | ||
| Ethanolamine | ↗ | Membrane phospholipid synthesis | ||
| Uridine | ↘ | Nucleoside, synthesis of RNA membrane, regulation of physiological processes |
a with creatinine.
b close to the signal of glutamine.
c tendency but without statistical significance (0.05 < p < 0.08).
Liver fatty acids for which the signals were significantly different between dams from the exposed and control groups (using the Kruskal Wallis test, p-value<0.05).
| Fatty acids | Variables | Tendancy |
|---|---|---|
| OSC:C20:4ω6 | ↗ | |
| OSC:C20:2ω6 | ↗ | |
| OSC:C20:3ω6 | ↗ | |
| OSC:C22:4ω6 | ↗ | |
| OSC:C18:0 | ↗ | |
| OSC:C22:5ω3 | ↗ | |
| OSC:C18:1ω7 | ↗ |
Fig 2Two-dimensional PCA scores plot of offspring rat samples integrated 1H NMR spectra.
2a: GD21 plasma samples (males only) (PCA, A = 3, R2 = 87.9%); 2b: GD21 aqueous liver extracts of males samples (PCA, A = 4, R2 = 76.7%); 2c: GD21 aqueous liver extracts of females samples (PCA, A = 4, R2 = 87.1%). Each dot represents an observation (animal), projected onto first (horizontal axis) and second (vertical axis) PCA variables. Control group is shown with black squares and the group exposed to eight pesticides widely used in Brittany (France) in 2004 (acetochlor, bromoxynil, carbofuran, chlormequat, ethephon, fenpropimorph, glyphosate, imidacloprid) is shown with red circles. The black ellipse determines the 95% confidence interval, which is drawn using Hotelling’s T2 statistic.
Results of the partial least square modelling of metabolic profiles of offspring (plasma, liver, and brain tissue extracts).
| Samples | Number of rats | Model used | Number of LV | R2 | Q2 | Intercepts | Number of VIP |
|---|---|---|---|---|---|---|---|
| 13 | PLS-DA (mean-centered) | 4 | 98.1% | 0.827 | R2 = (0.0, 0.753) Q2 = (0.0, -0.197) | 63 | |
| 15 | PLS-DA (pareto scaled) | 1 | 77.2% | 0.631 | R2 = (0.0, 0.353) Q2 = (0.0, -0.17) | 123 | |
| 20 | OSC-mean centered + PLS-DA (mean-centered) | 1 | 82.4% | 0.805 | R2 = (0.0, 0.037) | 3 | |
| 20 | PLS-DA (pareto scaled) | 3 | 85.1% | 0.474 | R2 = (0.0, 0.461) Q2 = (0.0, -0.273) | 78 | |
| 18 | OSC-mean-centered + PLS-DA (pareto scaled) | 3 | 90.4% | 0.754 | R2 = (0.0, 0.467) | 5 | |
| 17 | OSC-mean centered + PLS-DA (mean centered) | 2 | 87.2% | 0.668 | R2 = (0.0, 0.364) Q2 = (0.0, -0.295) | 48 | |
| 20 | PLS-DA (pareto scaled) | 4 | 98.7% | 0.783 | R2 = (0.0, 0.837) Q2 = (0.0, -0.367) | 147 |
apool of three rats.
b LV: latent variables.
c 200 permutations.
d VIP: variable importance in projection.
e exclusion of rats n°G2-m-bis, G2-m-ter et G0-47.
fexclusion of rat n°G0-42.
g exclusion of rat n°G0-43, G0-mter et G0-mbis.
Metabolites for which the levels were significantly different between offspring from exposed and non-exposed dams.
| Metabolite | Plasma ♂ | Aqueous Liver ♂ | Aqueous Liver ♀ | Aqueous Brain ♂ | Aqueous Brain ♀ | Biological role |
|---|---|---|---|---|---|---|
| Creatine | ↘ | ↘ | Amino-acid synthesis, storage energy | |||
| Lipids | ↗ | Lipid metabolism | ||||
| ADP + AMP | ↗ | Energy source | ||||
| Aspartate | ↘ | Non-essential amino-acid involved in urea cycle, DNA metabolism. Major excitatory neurotransmitter | ||||
| Succinate | ↗ | TCA cycle | ||||
| Alanine | ↘ | ↘ | Energy source, glucose metabolism regulator | |||
| Glutamate | ↘ | ↘ | ↘ | Neoglucogenesis, excitatory neurotransmitter | ||
| Glutamine | ↗ | ↘ | ↘ | Non-essential amino-acid, role in TCA-cycle | ||
| Glucose | ↗ | ↗ | Energy source | |||
| Glycogen | ↘ | ↘ | Energy storage | |||
| Glycerol | ↘ | ↘ | Lipid component, converted to glucose for energy production | |||
| Lactate | ↗ | ↗ | Energy metabolism | |||
| Leucine | ↘ | Essential amino-acid involved in stress, energy and muscle metabolism, role in cholesterol synthesis | ||||
| Lysine | ↗ | Essential amino-acid involved in stress, precursor of acetyl-coA | ||||
| Valine | ↘ | Branched-chain amino acid involved in stress, energy and muscle metabolism | ||||
| Inosine | ↗ ? | Purine nucleoside, intermediate in the degradation of purine nucleoside | ||||
| Oxidized gluthatione | ↘ | Antioxidant | ||||
| Taurine | ↗ | ↗ | ↗ | ↗ | Membrane stabilizer, anti-oxidant, osmolyte | |
| Glycerophosphocholine | ↗ | Membrane stabilizer, osmolyte | ||||
| Phosphocholine | ↗ | Membrane stabilizer, osmolyte | ||||
| Choline | ↘ | Precursor of acetylcholine, lipid metabolism | ||||
| Uridine | ↗ | Nucleoside, synthesis of RNA membrane, regulation of physiological processes |
a with creatinine.
b tendency but without statistical significance (0,05
c with acetate.
Liver fatty acids for which the levels were significantly different between male offspring from the exposed and control groups (using the Kruskal Wallis test, p-value<0.05).
| Fatty acids | Variables | Tendancy |
|---|---|---|
| Palmitic acid | OSC:C16:0 | ↘ |
| Stearic acid | OSC:C18:0 | ↘ |
| Oleic acid | OSC:C18:1ω9 | ↘ |
Fig 3Suggestion of cellular mechanisms that may be induced by the exposure of pregnant rat to a mixture of eight pesticides (acetochlor, bromoxynil, carbofuran, chlormequat, ethephon, fenpropimorph, glyphosate, imidacloprid) from GD 4 to GD 21.